Journal article
Clinical H-1 MRS in childhood neurometabolic diseases-part 1: technique and age-related normal spectra
Neuroradiology, Vol.64(6), pp.1101-1110
06/2022
DOI: 10.1007/s00234-022-02917-w
PMID: 35178593
Abstract
Despite its vigorous ability to detect and measure metabolic disturbances, H-1 MRS remains underutilized in clinical practice. MRS increases diagnostic yield and provides therapeutic measures. Because many inborn metabolic errors are now treatable, early diagnosis is crucial to prevent or curb permanent brain injury. Therefore, patients with known or suspected inborn metabolic errors stand to benefit from the addition of MRS. With education and practice, all neuroradiologists can perform and interpret MRS notwithstanding their training and prior experience. In this two-part review, we cover the requisite concepts for clinical MRS interpretation including technical considerations and normal brain spectral patterns based on age, location, and methodology.
Details
- Title: Subtitle
- Clinical H-1 MRS in childhood neurometabolic diseases-part 1: technique and age-related normal spectra
- Creators
- Matthew T. Whitehead - Children’s National Health SystemLillian M. Lai - Children's Hospital of Los AngelesStefan Bluml - Children's Hospital of Los Angeles
- Resource Type
- Journal article
- Publication Details
- Neuroradiology, Vol.64(6), pp.1101-1110
- Publisher
- Springer Nature
- DOI
- 10.1007/s00234-022-02917-w
- PMID
- 35178593
- ISSN
- 0028-3940
- eISSN
- 1432-1920
- Number of pages
- 10
- Language
- English
- Electronic publication date
- 02/18/2022
- Date published
- 06/2022
- Academic Unit
- Radiology
- Record Identifier
- 9984318710202771
Metrics
12 Record Views